Who we are
The Leeds Cancer Research UK (CRUK) Radiotherapy Centre of Excellence (RadNet Leeds) is one of a UK wide network of Radiotherapy Research Centres of Excellence. Our mission is to deliver smarter and kinder radiotherapy treatments, that are more specific to the individual patient and their tumour, using the latest radiotherapy technology and research. These treatments will reduce side effects and improve survival. We will do this through research that happens in the laboratory as well in face-to-face research with patients.
Our Vision
-
To deliver physically and biologically informed stratified and personalised radiotherapy in the primary curative and re-irradiation treatment setting to reduce toxicity and improve survival for cancer patients.
-
Deliver internationally leading clinical and translational research – as a CRUK Radiotherapy Research Centre and as part of the CRUK RadNet network.
- Support and train the next generation of researchers – using our outstanding multidisciplinary training environment.
CRUK RadNet Leeds – Making the news
- RadNet Leeds researchers take a lead role in a clinical trial of a ground-breaking new radiotherapy treatment. The APPROACH trial (Analysis of Proton vs Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health) is recruiting patients in Leeds, Manchester, Oxford, London, Cambridge and Kent. For more information, see here.
- £1.1 million in funding for Leeds prostate cancer trial https://yorkshirecancerresearch.org.uk/news/1-1-million-in-funding-for-leeds-prostate-cancer-trial
- Mail on Sunday https://www.dailymail.co.uk/health/article-8442699/Now-breast-lungbowel-prostate-cancer-treated-WEEK.html
Click here to view all of our RadNet Leeds Publications